Cancer Risk Reduction in Mexican American Women: The Role of Acculturation, Education, and Health Risk Factors

1995 ◽  
Vol 22 (1) ◽  
pp. 61-84 ◽  
Author(s):  
Hector Balcazar ◽  
Felipe G. Castro ◽  
Jennifer L. Krull
Cancers ◽  
2021 ◽  
Vol 13 (13) ◽  
pp. 3183
Author(s):  
Edward R. Sauter ◽  
Brandy Heckman-Stoddard

Metabolic (bariatric) surgery (MBS) is recommended for individuals with a BMI > 40 kg/m2 or those with a BMI 35–40 kg/m2 who have one or more obesity related comorbidities. MBS leads to greater initial and sustained weight loss than nonsurgical weight loss approaches. MBS provides dramatic improvement in metabolic function, associated with a reduction in type 2 diabetes mellitus and cardiovascular risk. While the number of MBS procedures performed in the U.S. and worldwide continues to increase, they are still only performed on one percent of the affected population. MBS also appears to reduce the risk of certain obesity related cancers, although which cancers are favorably impacted vary by study, who benefits most is uncertain, and the mechanism(s) driving this risk reduction are mostly speculative. The goal of this manuscript is to highlight 1) emerging evidence that MBS influences cancer risk, and that the potential benefit appears to vary based on cancer, gender, surgical procedure, and likely other variables; 2) the role of the NIH in MBS research in T2DM and CV risk for many years, and more recently in cancer; and 3) the opportunity for research to understand the mechanism(s) by which MBS influences cancer. There is evidence that women benefit more from MBS than men, that MBS may actually increase the risk of colorectal cancer in both women and men, and there is speculation that the benefit in cancer risk reduction may vary according to which MBS procedure an individual undergoes. Herein, we review what is currently known, the historical role of government, especially the National Institutes of Health (NIH), in driving this research, and provide suggestions that we believe could lead to a better understanding of whether and how MBS impacts cancer risk, which cancers are impacted either favorably or unfavorably, the role of the NIH and other research agencies, and key questions to address that will help us to move the science forward.


1999 ◽  
Vol 41 (10) ◽  
pp. 863-877 ◽  
Author(s):  
Wayne N. Burton ◽  
Daniel J. Conti ◽  
Chin-Yu Chen ◽  
Alyssa B. Schultz ◽  
Dee W. Edington

2003 ◽  
Author(s):  
Cedric F. Garland ◽  
Frank C. Garland ◽  
Edward D. Gorham ◽  
Martin Lipkin ◽  
Harold Newmark ◽  
...  

2018 ◽  
Vol 10 (1) ◽  
pp. 55-57
Author(s):  
Klaus R. Scherer

I strongly endorse many of the suggestions made by the authors of the extremely useful reviews in this issue. In particular, the need to identify the complex causal mechanisms underlying the major health risk factors requires urgent attention of the research community. I suggest considering the important role of emotional disturbances as contributors to health risks given the empirically established comorbidity between mental and somatic illness. Better knowledge of these mechanisms is an essential prerequisite to develop tailored personalized prevention and intervention programs, including reliable and valid assessment of deficits.


Sign in / Sign up

Export Citation Format

Share Document